T-flex Aspheric Toric

How many of your cataract patients would benefit from a T-flex Aspheric Toric IOL?

Prevalence of pre-operative corneal astigmatism in a cross-sectional study of 746 patients (1230 eyes):¹³

• Over 40 % presented with >1.0 D of astigmatism
• More than 20 % presented with >1.5 D of astigmatism

Why leave your post-operative patients with residual astigmatism?

Proven rotational stability² with predictable, sustainable and accurate visual results

Designed with AVH Technology for excellent fixation within the capsular bag:¹

• Progressively taking up the forces generated within the contracting capsular bag
• Maintaining excellent centration with rotational, torsional and directional stability

In a prospective study of 27 eyes in 22 consecutive patients with >1.5 D regular corneal astigmatism, at three months post-operatively, variations from intended axis were:²

References:

1. Claoué C. Clinical and Surgical Ophthalmology 2008; 26(6): 198-200.
2. Alberdi R et al. J Refract Surg 2012; 28(10); 696-700.
13. Khan M and Muhtaseb M. JCRS 2011; doi: 10.1016/j.jcrs.2011.04.026.

Sulcoflex Toric  IOLs are supplied with a Rayner injector

T-flex Aspheric Toric IOLs are supplied with a Rayner injector

• Uniquely designed loading bay with an extension “lip” to facilitate loading.
• Soft plunger tip completely fills the nozzle and offers a soft protective interface with the IOL.
• Syringe-style design for single-handed technique for smooth IOL delivery with predictable and efficient insertion, ensuring consistent IOL implantations.
• Sterile Single-Use, ready to use.

T-flex Aspheric Toric Technical Information

*Please note that the constants indicated for all Rayner lenses are estimates and are for guidance purposes only. Surgeons must always expect to personalise their own constants based on initial patient outcomes, with further personalisation as the number of eyes increases.

T-flex Aspheric Toric regulatory

Not all products or offerings are approved or offered in every market and approved labelling and instructions may vary from one country to another. For country specific product information contact your local distributor or email enquires@rayner.com.

This product is not approved by the FDA for use or distribution in the United States of America.

Rayner hold a selection of EC certificates for various products. Please contact the Regulatory Affairs team for the current version.

T-flex Aspheric Toric peer review papers

• Findl O, Koshy J, Hirnschall N, Vyas A, Narendran R, Crnej A, Gangwani V, Nishi Y and Maurino V: Comparing capsular bag performance of a hydrophilic and a hydrophobic intraocular lens: A randomised two-centre study. European Journal of Ophthalmology 2018 March
• Weng SW , Wangemail JK, Chang SW,  Mai ELC. Use of a T-flex toric intraocular lens to correct clinically significant astigmatism. Taiwan Journal of Ophthalmology 4 (2014) 170-173
• Hirnschall N,  Hoffmann PC, Draschl P, Maedel S, Findl O. Evaluation of Factors Influencing the Remaining Astigmatism After Toric Intraocular Lens Implantation. J Refract Surg. 2014 Jun;30(6):394-400
• Alberdi T, Macías-Murelaga B, Bascarán L, Goñi N, de Arregui SS, Mendicute J. Rotational stability and visual quality in eyes with Rayner toric intraocular lens implantation. J Refract Surg. 2012 Oct;28(10):696-701
• Entabi M, Harman F, Lee N, Bloom PA. Injectable 1-piece hydrophilic acrylic toric intraocular lens for cataract surgery: Efficacy and stability. J Cataract Refract Surg. 2011 Feb;37(2):235-40

Trade papers:

• Black D. Acrylic toric IOL achieves optimal visual outcomes. Ocular Surgery News Asia Pacific Edition, June 2011

White papers:

• The Rayner Line of Toric IOLs: Highlights of Recently Published Clinical Studies.

T-flex Aspheric Toric videos

T-flex Aspheric Toric marketing materials